会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 5-aminoflavone derivatives
    • 5-氨基黄酮衍生物
    • US5539112A
    • 1996-07-23
    • US464093
    • 1995-06-05
    • Tsutomu AkamaShun-ichi IkedaYasushi ShidaMasaji KasaiHiroyuki IshidaUichiro KimuraKatsushige GomiHiromitsu SaitoKimihisa Ueno
    • Tsutomu AkamaShun-ichi IkedaYasushi ShidaMasaji KasaiHiroyuki IshidaUichiro KimuraKatsushige GomiHiromitsu SaitoKimihisa Ueno
    • C07D311/30C07D413/12
    • C07D311/30
    • 5-Aminoflavone derivatives represented by the formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are the same or different and represent hydrogen, substituted or unsubstituted lower alkyl, lower alkenyl, halogen-substituted or unsubstituted lower alkanoyl or lower alkoxycarbonyl, X.sup.1, X.sup.2, Y.sup.1 and Y.sup.2 are the same or different and represent hydrogen, halogen or lower alkyl, at least one of X.sup.1 and X.sup.2 represents halogen or lower alkyl, X.sup.3 represents hydrogen, substituted or unsubstituted lower alkyl, lower alkenyl, lower alkynyl, halogen, hydroxy, substituted or unsubstituted lower alkoxy, NR.sup.5 R.sup.6 (wherein R.sup.5 and R.sup.6 are the same or different and represent hydrogen, or substituted or unsubstituted lower alkyl, or R.sup.5 and R.sup.6 are taken together to form a heterocyclic group containing the nitrogen atom in the ring), lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, carboxy, lower alkoxycarbonyl, lower alkanoyl, adizo, cyano, substituted or unsubstituted carbamoyl or lower alkylthiothiocarbonyl: or pharmaceutically acceptable salts thereof.
    • 由式(I)表示的5-氨基黄酮衍生物:其中R 1,R 2,R 3和R 4相同或不同,表示氢,取代或未取代的低级烷基,低级烯基,卤素取代或未取代的低级 烷酰基或低级烷氧基羰基,X 1,X 2,Y 1和Y 2相同或不同,表示氢,卤素或低级烷基,X 1和X 2中的至少一个表示卤素或低级烷基,X 3表示氢,取代或未取代的低级烷基,低级 烯基,低级炔基,卤素,羟基,取代或未取代的低级烷氧基,NR5R6(其中R5和R6相同或不同,代表氢,或取代或未取代的低级烷基,或R5和R6一起形成含有 环中的氮原子),低级烷硫基,低级烷基亚磺酰基,低级烷基磺酰基,羧基,低级烷氧基羰基,低级烷酰基,二唑基,氰基,取代或未取代的氨基甲酰基或低级烷硫基硫代 辛基或其药学上可接受的盐。
    • 3. 发明申请
    • Drug for nerve regeneration
    • 药物用于神经再生
    • US20060217368A1
    • 2006-09-28
    • US10552061
    • 2004-04-16
    • Tsuyoshi MorishitaKazuhiro SakuradaKeiko SuzukiShun-ichi Ikeda
    • Tsuyoshi MorishitaKazuhiro SakuradaKeiko SuzukiShun-ichi Ikeda
    • A61K31/55A61K31/404A61K33/00A61K31/407A61K31/405
    • A61K31/00A61K31/404A61K31/4045A61K31/407A61K31/553
    • An object of the present invention is to provide a nerve regenerating drug, an agent for the promotion of neuropoiesis of a neural stem cell, a neuron obtained by culturing a neural stem cell in the presence of the agent for the promotion of neuropoiesis, and a method of the manufacture of the neuron. In order to achieve the object, the invention provides a nerve regenerating drug comprising a substance that inhibits the activity of glycogen synthase kinase-3, as an active ingredient; an agent for the promotion of neuropoiesis of a neural stem cell comprising the substance as an active ingredient; a neuron obtained by culturing a neural stem cell in the presence of the agent for the promotion of neuropoiesis; and a method of the manufacture of the neuron. The medical drug according to the invention is useful as a therapeutic drug for neurological diseases such as Parkinson's disease, Alzheimer's disease, Down's disease, cerebrovascular disorder, cerebral stroke, spinal cord injury, Huntington's chorea, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, anxiety disorder, schizophrenia, depression and manic depressive psychosis.
    • 本发明的目的是提供一种神经再生药物,用于促进神经干细胞神经生成的药剂,通过在用于促进​​神经生成的药剂的存在下培养神经干细胞获得的神经元,以及 神经元的制造方法。 为了达到上述目的,本发明提供了包含抑制糖原合成酶激酶-3活性的物质作为活性成分的神经再生药物。 用于促进包含该物质作为活性成分的神经干细胞神经生成的药剂; 在用于促进​​神经生成的药剂存在下培养神经干细胞获得的神经元; 以及神经元的制造方法。 根据本发明的药物可用作神经疾病如帕金森病,阿尔茨海默氏病,唐氏病,脑血管病,脑卒中,脊髓损伤,亨廷顿舞蹈病,多发性硬化,肌萎缩性侧索硬化,癫痫,焦虑症的治疗药物 失调,精神分裂症,抑郁症和躁狂抑郁症精神病。